Furthermore, most of these studies lack clinical information regarding the presence of insulin resistance (diabetes mellitus condition was a criterion of exclusion) as well as data regarding the alterations of IGF axis in the tumors studied. The gene discussed is IGF1; the disease is Insulin resistance.